Tykerb (Lapatinib) 250mg Online

$700.00

Tykerb is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat some advanced breast cancers. It is often used along with other cancer treatments.

Description

Tykerb (Lapatinib) 250mg Online

Tykerb (Lapatinib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing.
It is used to treat some advanced breast cancers. It is often used along with other cancer treatments.

Tykerb Lapatinib is used with capecitabine (Xeloda) to treat a certain type of advanced breast cancer in people who have already been treated with other chemotherapy medications. Lapatinib is also used with letrozole (Femara) to treat a certain type of breast cancer in postmenopausal women (women who have experienced a change of life; end of menstrual periods) that has spread to other parts of the body. Tykerb is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells.

Tykerb Lapatinib comes as a tablet to take by mouth. It is usually taken once a day, at least 1 hour before or 1 hour after a meal. When Tykerb is used to treat advanced or metastatic breast cancer, it is usually given once daily on days 1 to 21 (along with capecitabine on days 1 to 14) of a 21-day cycle. The cycle may be repeated as recommended by your doctor. When lapatinib is used to treat breast cancer in postmenopausal women, it is usually given once daily along with letrozole. Take all of the lapatinib tablets for your daily dose at one time each day; do not divide the tablets to take as separate doses. Take lapatinib at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take lapatinib exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.